USD/INR Enters Uncharted Territory Amid Weakness In Indian Rupee
The Indian Rupee (INR) refreshes its all-time low around 89.10 against the US Dollar (USD) at open on Wednesday.
Time To Buy Pfizer Or Metsera Stock?
Making a major move in the obesity drug market, Pfizer announced on Monday that it plans to acquire biotechnology firm Metsera by the end of the year for $4.9 billion or $47.50 a share.
Gold Trading Strategy, XAUUSD Analysis & Forecast - Wednesday, Sept 24
Today you will see Gold price predictions based on technical analysis. What is the support and resistance on the daily time frame for XAUUSD?
